Akoya Biosciences Company Overview
About Akoya Biosciences
Akoya Biosciences (NASDAQ:AKYA) operates within the biotechnology sector, focusing on developing and providing advanced imaging solutions to analyze biological samples at a cellular and molecular level. The company's projects are aimed at enhancing precision medicine, with its technologies being crucial in areas such as cancer research, immunology, and various biomedical research fields. Akoya Biosciences' objective is to transform the understanding of biology and disease markers by delivering comprehensive and deep insights that enable researchers and clinicians to make informed decisions. With a commitment to innovation, the company continuously seeks to expand its portfolio of imaging solutions, collaborating with the scientific community to support breakthrough discoveries in health and disease.
Snapshot
Operations
Produtos e/ou serviços de Akoya Biosciences
- Phenoptics™ Research Solution: An advanced tissue imaging system providing insights into the tumor microenvironment for cancer research and drug development.
- Codex®: A highly multiplexed imaging platform enabling the analysis of up to 60 proteins on a single tissue slide, designed for comprehending cellular interactions.
- Proxima™: A cloud-based image data management and analysis platform, optimizing access, sharing, and storage of imaging data for collaborative research.
- Vectra® Polaris™: An automated quantitative pathology imaging system that combines multispectral imaging with whole-slide scanning for advanced tissue analysis.
- Opal™ Polaris Multiplex IHC Kits: Reagents and protocols designed for use with the Vectra® Polaris™ to facilitate multiplex immunohistochemistry, enabling detailed tissue imaging.
- Mantra™ Quantitative Pathology Workstation: A desktop solution for quantitative pathology imaging, ideal for research labs needing to analyze tissue sections with fluorescence and brightfield imaging.
equipe executiva do Akoya Biosciences
- Mr. Brian McKelligonPresident, CEO & Director
- Mr. John Frederick Ek CPACFO & Principal Accounting Officer
- Dr. Niroshan Ramachandran Ph.D.Chief Business Officer
- Mr. Anthony CatalanoSenior Vice President of Operations
- Mr. Priyam ShahSenior Director of Business Development & Investor Relations Strategy
- Ms. Jennifer KamocsayChief Legal Officer
- Dr. Pascal Bamford Ph.D.Chief Clinical Officer
- Mr. Rob C. Hart C.F.A., CFA, J.D.Secretary